ID
41942
Description
Study ID: 110921 Clinical Study ID: 110921 Study Title: A Phase II Trial of Ofatumumab in Subjects with Waldenstrom's Macroglobulinemia Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00811733 Clinicaltrials.gov Link: https://clinicaltrials.gov/ct2/show/NCT00811733 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Ofatumumab Trade Name: N/A Study Indication: Waldenstrom Macroglobulinaemia The primary objective of this open-label, multi-center, Phase II study was to evaluate the safety and efficacy of Ofatumumab in subjects diagnosed with Waldenstrom Macroglobulinaemia. For the study, eligible subjects were enrolled to receive up to 3 cycles of treatment with Ofatumumab. The first cycle consisted of a single dose of 300 mg followed by 3 weekly doses of 1000 mg (Treatment Group A) or 4 weekly doses of 2000 mg (Treatment Group B) of Ofatumumab, with response assessment beginning at Week 12. Based on the Week 12-16 response, eligible subjects could receive up to 2 additional cycles of treatment. This form has to be filled out at the Screening Visit, the first and last weekly visits during the cycles of therapy, the cycle observation visits, unscheduled visits, withdrawal visits and the visits at the end of study/treatment.
Link
https://clinicaltrials.gov/ct2/show/NCT00811733
Keywords
Versions (1)
- 2/19/21 2/19/21 -
Copyright Holder
GlaxoSmithKline
Uploaded on
February 19, 2021
DOI
To request one please log in.
License
Creative Commons BY-NC 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
GSK Ofatumumab in Waldenstrom Macroglobulinaemia, NCT00811733
Physical Examination
- StudyEvent: ODM
Description
Physical Lymph Node Examination
Alias
- UMLS CUI-1
- C0031809
- UMLS CUI-2
- C0024204
Description
Please choose the location of the palpation, then answer the following questions
Data type
integer
Alias
- UMLS CUI [1,1]
- C0030247
- UMLS CUI [1,2]
- C0450429
Description
Please record palpable lymph nodes (> = 1.5cm)
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0024204
- UMLS CUI [1,2]
- C0522499
Description
Please specify the size of the largest palpable lymph node
Data type
integer
Measurement units
- cm
Alias
- UMLS CUI [1,1]
- C0024204
- UMLS CUI [1,2]
- C0487742
Description
Please specify the size of the largest palpable lymph node
Data type
integer
Measurement units
- cm
Alias
- UMLS CUI [1,1]
- C0024204
- UMLS CUI [1,2]
- C1444754
Description
If yes, please specify the size of the largest palpable lymph node
Data type
integer
Measurement units
- cm2
Alias
- UMLS CUI [1,1]
- C0024204
- UMLS CUI [1,2]
- C0456389
Description
Physical Organ Exam
Alias
- UMLS CUI-1
- C0031809
- UMLS CUI-2
- C0178784
Description
Hepatomegaly
Data type
boolean
Alias
- UMLS CUI [1]
- C0019209
Description
Liver size below costal margin
Data type
integer
Measurement units
- cm
Alias
- UMLS CUI [1,1]
- C0456389
- UMLS CUI [1,2]
- C0023884
- UMLS CUI [1,3]
- C0542339
- UMLS CUI [1,4]
- C1288448
Description
Splenomegaly
Data type
boolean
Alias
- UMLS CUI [1]
- C0038002
Description
Spleen size below costal margin
Data type
integer
Measurement units
- cm
Alias
- UMLS CUI [1,1]
- C0037993
- UMLS CUI [1,2]
- C0456389
- UMLS CUI [1,3]
- C0542339
- UMLS CUI [1,4]
- C1288448
Similar models
Physical Examination
- StudyEvent: ODM
C2985720 (UMLS CUI [2])
C0024204 (UMLS CUI-2)
C0450429 (UMLS CUI [1,2])
C0522499 (UMLS CUI [1,2])
C0487742 (UMLS CUI [1,2])
C1444754 (UMLS CUI [1,2])
C0456389 (UMLS CUI [1,2])
C0023884 (UMLS CUI [1,2])
C0542339 (UMLS CUI [1,3])
C1288448 (UMLS CUI [1,4])
C0456389 (UMLS CUI [1,2])
C0542339 (UMLS CUI [1,3])
C1288448 (UMLS CUI [1,4])
No comments